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construction of a synthetic 
pathway for the production of 
1,3-propanediol from glucose
Cláudio J. R. frazão1, Débora trichez1, Hélène Serrano-Bataille1, Adilia Dagkesamanskaia1, 
Christopher M. topham2, Thomas Walther1,3,4 & Jean Marie françois  1,3
In this work, we describe the construction of a synthetic metabolic pathway enabling direct 
biosynthesis of 1,3-propanediol (PDO) from glucose via the Krebs cycle intermediate malate. This 
non-natural pathway extends a previously published synthetic pathway for the synthesis of (L)-2,4-
dihydroxybutyrate (L-DHB) from malate by three additional reaction steps catalyzed respectively, by 
a DHB dehydrogenase, a 2-keto-4-hydroxybutyrate (OHB) dehydrogenase and a PDO oxidoreductase. 
Screening and structure-guided protein engineering provided a (L)-DHB dehydrogenase from the 
membrane-associated (L)-lactate dehydrogenase of E. coli and OHB decarboxylase variants derived 
from the branched-chain keto-acid decarboxylase encoded by kdcA from Lactococcus lactis or pyruvate 
decarboxylase from Zymomonas mobilis. The simultaneous overexpression of the genes encoding these 
enzymes together with the endogenous ydhD-encoded aldehyde reductase enabled PDO biosynthesis 
from (L)-DHB. While the simultaneous expression of the six enzymatic activities in a single engineered 
E. coli strain resulted in a low production of 0.1 mM PDO from 110 mM glucose, a 40-fold increased 
PDO titer was obtained by co-cultivation of an E. coli strain expressing the malate-DHB pathway with 
another strain harboring the DHB-to-PDO pathway.
A central goal of the bioeconomy consists in reducing our dependence on petroleum by focusing on the devel-
opment of efficient, sustainable and eco-friendly processes for production of bio-based chemicals and fuels1,2. 
1,3-Propanediol (PDO) is an important commodity chemical that can serve as a precursor monomer for the 
synthesis of industrially relevant polymers, including polyesters, polyethers and polyurethanes. Among those, the 
polyester polytrymethylene terephthalate (PTT) is foreseen as a major competitor of Nylon in carpet industries, 
therefore making PDO a molecule of significant industrial interest. While both acrolein hydration, and ethylene 
oxide hydroformylation followed by reduction of resulting aldehyde enable PDO synthesis, low product yields 
and harsh reaction conditions impede the successful development of a cost-competitive chemical production 
process3–5.
Alternatively, PDO can be produced from glycerol by Klebsiella, Clostridium, Citrobacter, Enterobacter 
or Lactobacillus species under anaerobic conditions in a two-step reductive pathway that employs vitamin 
B12-dependent glycerol dehydratase and PDO oxidoreductase enzymatic activities5. More recently, the occurrence 
of a vitamin B12-independent glycerol dehydratase in C. butyricum (Cb-DhaB1) has also been demonstrated and 
employed for PDO biosynthesis6. PDO biosynthesis from glycerol has previously been shown to be extremely 
efficient. For instance, batch cultivation of K. pneumoniae enabled the production of up to 60 g L−1 PDO at a high 
formation rate (1.4 g L−1 h−1) and good yield (0.35 g PDO per g glycerol)3. A particularity of the PDO pathway 
starting from glycerol is that product yield remains dependent on the intracellular availability of the NADH 
co-factor. While anaerobic cell growth on glycerol (oxidative pathway) ensures NADH formation, co-factor 
regeneration needs the additional formation of a by-product to serve as electron sink (e.g. acetate, butyrate, etha-
nol, butanol). Together with the fact that glycerol dehydratases are inhibited by the presence of substrate/product 
at elevated concentration, titre and production rates of PDO to be achieved are limited unless newly discovered 
or engineered enzymes are found to be less sensitive to the substrate/product couple7,8. In attempt to demonstrate 
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additional entry points for PDO production and overcome the potential challenges imposed by glycerol fermen-
tation, various strategies were developed to synthesize PDO from sugar feedstock. While no natural microorgan-
isms have been found to directly convert sugars to PDO, the adoption of two-stage and co-fermentation processes 
was shown to enable a better control of cultivation conditions and a wider flexibility in terms of substrate utiliza-
tion5,9,10. Another approach is the engineering of microorganisms for the direct production of PDO from sugars 
via glycerol, which led Genencor and DuPont to develop a fermentation process employing a genetically modified 
E. coli strain able to produce PDO aerobically at high titer and yield11. In both cases, the engineered PDO path-
ways are composed of the necessary reaction steps linking the glycolysis-derived metabolite dihydroxyacetone 
phosphate (DHAP) to PDO via glycerol (Fig. 1B), thereby increasing the theoretical product yield by 50% (1.5 
mol PDO per mol glucose) when compared to the utilization of glycerol as carbon source. While in the last 
decade glycerol costs dropped considerably reaching prices which today are inferior to that of glucose, the main 
advantage of glucose-based processes is the substantially increased product titers and rates as in theory glycerol is 
not accumulated at high-titers and glycerol dehydratases become no longer rate-limiting12.
Traditional metabolic engineering resulted in great improvements in PDO biosynthesis, but the rapid devel-
opment of powerful genome mining and protein engineering tools enable now the creation of de novo designed 
non-natural pathways for the production of economically relevant compounds13. In this regard, an artificial path-
way enabling PDO to be synthesized from glucose or sucrose was previously implemented in E.coli by extending 
the naturally occurring aspartate-homoserine pathway (Fig. 1C). The proposed pathway has a similar theoretical 
product yield than that of Dupont’ route and does neither involve glycerol as intermediate nor the utilization of 
glycerol dehydratase enzymes, and is therefore very appealing for PDO production. This approach, which has 
been patented by METEX14, involves an enzyme bearing amino transferase activity on homoserine, followed by 
the decarboxylation of 2-keto-4-hydroxybutyrate (OHB) by a keto-acid decarboxylase, and finally the reduction 
of hydroxypropanal (3-HPA) to PDO by an enzyme with 1,3-propanediol oxidoreductase activity. While the 
last reaction of this artificial pathway is catalyzed by the broad substrate range NADPH-dependent aldehyde 
reductase encoded by yqhD gene from E. coli (Ec-yqhD)15, the two preceding enzymatic reactions are not known 
to naturally occur in cell metabolism. In demonstration of this pathway, these authors have engineered an E. coli 
strain overexpressing the native serC-encoded transaminase (Ec-SerC) and the branched-chain 2-ketoisovalerate 
decarboxylase from Lactococcus lactis (Ll-KivD)16. In a complementary study, the poorly effective homoserine 
transaminase in this pathway has been replaced by a homoserine dehydrogenase obtained by rational engineering 
of either an E. coli NADP-dependent glutamate dehydrogenase17 or Ec-SerC18. However, PDO titer obtained with 
these engineered enzymes was still in the range of mg per liter, suggesting that the deamination of homoserine is 
rate limiting in the pathway.
To overcome this problem and propose an new alternative pathway for PDO synthesis from glucose, 
we took advantage of our recent synthetic pathway leading to the production the non-natural metabolite 
(L)-2,4-dihydroxybutyrate (L-DHB) that departs from the TCA cycle intermediate malate through three 
non-natural enzymatic reaction steps19. As described in Fig. 1D, malate is converted to malyl-phosphate by 
Figure 1. Natural (A) and engineered metabolic pathways (B–D) enabling biosynthesis of 1,3-propanediol 
(PDO). The standard Gibbs free energy values of each individual reaction was taken from EcoCyc database 
when available (denoted as *). Otherwise, values were estimated based on the group contribution theory43 
(denoted as **).
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employing malate kinase, followed by a malate semialdehyde dehydrogenase and then malate semialdehyde 
reductase activities to yield L-DHB. Extending this pathway with (L)-DHB dehydrogenase, OHB decarboxy-
lase and PDO oxidoreductase shall eventually produce PDO. Our proposed pathway has a theoretical product 
yield identical to other PDO pathways starting from glucose (1.5 mol per mol glucose), and consumes 1 mol of 
ATP and 3 mol of NADPH per consumed mol of malate, being well suited for aerobic based-processes. Based 
on enzyme screening and engineering approaches, the required enzyme activities were improved and found to 
enable in vivo PDO production from DHB. While simultaneous expression of all six enzymatic activities in one E. 
coli strain enabled direct PDO production from glucose, distributing the malate-to-DHB and the DHB-to-PDO 
pathway modules into two E. coli strains co-cultivated in mineral medium further improved PDO titer.
Results
Design of the PDO synthetic pathway. In a previous study, we designed and experimentally validated a 
de novo metabolic pathway leading to the production of (L)-DHB from glucose via malate by expressing malate 
kinase, malate semialdehyde dehydrogenase and malate semialdehyde reductase enzyme activities in E. coli19. 
While DHB can be transformed to the methionine-analog HMTB by chemical means20, we herein demonstrate 
that this non-natural metabolite may also serve as a precursor for the microbial production of PDO. The con-
version of (L)-DHB to PDO proceeds via three reaction steps (Fig. 1D): (L)-DHB is first oxidized to OHB, the 
resulting α-keto acid is then decarboxylated to yield 3-HPA, which is finally reduced into PDO. These reactions 
are catalyzed by enzymes bearing (L)-DHB dehydrogenase, OHB decarboxylase and PDO oxidoreductase activ-
ities, respectively. The negative standard Gibbs free energy for the proposed pathway attests its thermodynamic 
feasibility (Table S1 and Note 1 in Supplementary Information). Stoichiometric analysis of the metabolic network 
in E. coli shows that PDO can be produced from glucose with a theoretical maximum yield of 1.5 mol mol−1 in 
the absence of cell growth (Fig. S1 and Note 2 in Supplementary information). The theoretical yield of PDO 
is similar to those from glucose via homoserine17 and via glycerol11. Implementation of the pathway requires 
enzymes bearing the three constitutive enzymatic activities. The promiscuous broad range aldehyde reductase 
encoded by yqhD in E. coli was previously shown to catalyze the reduction of 3-HPA to PDO Jarboe, 2011 #9565}, 
and was therefore used in our work. The Zymomonas mobilis pyruvate decarboxylase was found to exhibit OHB 
decarboxylase activity17, while to the best of our knowledge no natural (L)-DHB dehydrogenase activity has been 
reported to date.
Engineering of (L)-DHB dehydrogenase activity. In a recent work, we showed that 
the soluble NAD-dependent (L)-malate dehydrogenase enzyme variant from E. coli Ec-Mdh-5Q 
(I12V:R81Q:M85Q:D86S:G179D) was able to oxidize DHB into OHB as substrate21. However, the unfavorable 
thermodynamics of NAD-dependent DHB oxidation (ΔrG0 = 15.7 kJ mol−1) together with the low affinity of this 
enzyme variant for (D/L)-DHB (Km ~ 130 mM) prompted us to screen for alternative DHB dehydrogenase candi-
date enzymes. Remarkably, E. coli MG1655 wild-type cells were found to possess the capability to assimilate 20% 
of 50 mM (D/L)-DHB after 24h of cultivation in mineral medium (data not shown). The identification of enzymes 
responsible for this assimilation of DHB dehydrogenase was therefore investigated. In particular, E. coli displays 
a set of three lactate dehydrogenase enzymes able to catalyze the interconversion between L- and D-lactate and 
pyruvate encoded by ldhA, llDd, dld genes. The Ec-LldD and LlldD enzyme relies on FMN and FAD-dependent 
co-factor system, respectively22,23, which allow the oxidation of lactate (ΔrG0 = −23.1 kJ mol−1; Note 2 in 
Supplementary information). Since the deletion of the corresponding lldD gene in E. coli nearly abolished DHB 
consumption (less than 1% consumption after 24h of cell cultivation, not shown), we decided to further char-
acterize the Ec-LldD enzyme as a putative DHB dehydrogenase. To this end, the wild-type Ec-LldD enzyme 
was produced from a pET28-derived vector expressed in E. coli BL21 (DE3). As LldD is a membrane-associated 
enzyme and hence hardly to purify to homogeneity, we evaluated Vmax and KM of this enzyme directly on in crude 
protein extracts owing to the fact that the measured activity of this enzyme was highly reproducible from inde-
pendent cultures expressing this gene in pET28+. While LldD activity on DHB and on (L)-lactate in cells bearing 
an empty plasmid was barely detectable (Vmax < 0.01 U mg−1; Table 1), overexpression of the gene encoding this 
enzyme resulted in a more than 50 fold increase of activity on these two substrates. However, the activity as well 
as the affinity of LldD on DHB were respectively 4 and 250 fold lower than on L-lactate (Table 1). Although these 
data were obtained on crude extracts and therefore does not provide true kinetic constant (kcat) and catalytic effi-
ciency (kcat/KM), they clearly justify for a rational engineering of LldD with the expectation to increase the affinity 
of this enzyme towards DHB.
Plasmid
(L)-lactate (D/L)-2,4-dihydroxybutyrate
Vmax [U mg−1]a KM [10−3 M] Vmax [U mg−1]a KM [10−3 M]
pET28 0.01 (±0.000)c nd 0.01 (±0.0005)c —
pET28-Ec-LlDd 2.1 (±0.2) 0.04 (±0.01) 0.6 (±0.1) 10.6 (±0.7)
pET28-Ec-LlDdV108C 3.0 (±0.5) 0.2 (±0.0) 0.5 (±0.1) 6.6 (±0.8)
Table 1. Membrane-associated 2-hydroxyacid dehydrogenase activities of E. coli BL21(DE3) cells expressing 
candidate his-tagged DHB dehydrogenases from the high-copy pET28 plasmid. Data presented as the mean 
(±S.D.) of at least two replicates. aActivities were estimated in U mg−1 crude protein extract. bSpecificity 
corresponds to the ratio of (vmax/Km) between the natural substrate (L)-lactate and (D/L)-DHB. cSince no 
saturation was observed, activities were measured in the presence of either 50 mM (L)-lactate or 100 mM (D/L)-
DHB. nd: not determined.
4Scientific RepoRtS |         (2019) 9:11576  | https://doi.org/10.1038/s41598-019-48091-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Amino acid residues responsible for substrate specificity in Ec-LldD were identified by visual inspection of 
the crystal structure of the homologous protein from Saccharomyces cerevisiae (Sc-Cyb2) bound to the reaction 
product pyruvate and the co-factor FMN24. Key residues in the active site of Sc-Cyb2 are shown in Fig. 2. The neg-
ative charge of the α-carboxylate group of pyruvate is neutralized by electrostatic interaction with Arg376, while 
residues Leu199, Leu230, Leu286, Tyr254 and Phe325 delimit the active site pocket. The catalytic residue His373 
deprotonates the α-hydroxyl group of (L)-lactate, but the mechanism of substrate oxidation is still not clear. 
The pivotal role of those residues in substrate binding was previously discussed25. In the same study, amino acid 
substitution at residue Leu230 (corresponding to Val108 in Ec-LldD), which is in contact with the methyl group 
of pyruvate, was demonstrated to confer activity on larger substrates (e.g. mandelate). We therefore replaced 
valine in position 108 by smaller amino acid residues such as alanine, serine, cysteine and glycine, and analyzed 
the activities of resulting mutants (data not shown). Only the V108C variant resulted in an improved affinity for 
DHB (Km = 6.6 mM) when compared to the wild-type enzyme (Km = 10.6 mM; Table 1). While the increase in 
affinity towards the synthetic substrate was marginal, a decrease over 2-orders of magnitude in affinity towards 
(L)-lactate was observed.
Engineering of OHB decarboxylase activity. The enzymes Zm-Pdc and the branched-chain ketoacid 
decarboxylase from L. lactis (Ll-KdcA) have been reported to possess activity on various 2-ketoacids, yielding 
corresponding aldehydes and carbon dioxide as reaction products24. Due to the structural similarity between 
OHB and 2-ketoacids, we therefore examined activities of these two enzymes on OHB. Results in Table 3 shows 
that both enzymes displayed OHB decarboxylase activities. However, as expected, they have a preference of up 
to 3-orders of magnitude for their natural substrate as compared to OHB. We therefore sought to engineer these 
two α-keto acid decarboxylase enzymes for higher catalytic efficiency towards OHB substrate by site-directed 
mutagenesis.
Manual docking of OHB into the active site pocket of Zm-Pdc revealed the substrate binding site to be too 
small for accommodation of this substrate (Fig. 3A). We speculated that the possible clash of the bulky tryptophan 
residue at position 392 located in the deep cleft leading to the active site with OHB can be avoided by replacement 
with glutamine (Fig. 3B), which may then be able to hydrogen bond with the 4-OH hydroxyl group. This W392Q 
mutation in Zm-Pdc resulted in a slight 1.4-fold increase of catalytic efficiency on OHB but also in nearly 100-fold 
reduction of its catalytic efficiency towards the natural substrate pyruvate (Table 2). This result suggested that it is 
Figure 2. Active site region in the X-ray crystal structure of S. cerevisiae flavocytochrome B2 (Sc-Cyb2) (PDB 
code 1fcb). The residues in contact with reaction product pyruvate (pyr) are highlighted.
Enzyme
Natural substratea 2-keto-4-hydroxybutyrate
Specificityc
Vmax [U 
mg−1]
KM [10−3 
M]
Vmax/KM [U mg−1 
M−1]b Vmax [U mg−1]
KM [10−3 
M]
Ki [10−3 
M]
Vmax/KmM 
[U mg−1 
M−1]b
Zm-Pdc 49.56 (±1.20) 1.7 (±0.2) 29,416 (±4,625) 0.01 (±0.0003) 0.4 (±0.2) — 34 (±13) 864
Zm-Pdc W392Q 1.74 (±0.32) 5.2 (±0.3) 335 (±83) 0.02 (±0.004) 0.5 (±0.2) 5.0 (±0.4) 46 (±23) 7
Ll-KdcA 2.66 (±0.17) 2.7 (±0.2) 416 (±43) 0.02 (±0.001) 2.5 (±1.6) — 9 (±5) 48
Ll-KdcA V461I 2.89 (±0.52) 5.1 (±1.1) 590 (±233) 0.04 (±0.0001) 1.3 (±0.5) — 31 (±12) 19
Table 2. Kinetic parameters of candidate OHB decarboxylases on 2-keto-4-hydroxybutyrate (OHB) and 
corresponding natural substrates. Data presented are the mean (±S.D.) of at least two replicates. aNatural 
substrates were used as follows: pyruvate for Zm-Pdc, 3-methyl-2-ketobutyric acid for Ll-KdcA. bActivities 
were estimated in U mg−1 purified protein. cSpecificity corresponds to the ratio of (vmax/Km) between natural 
substrate and OHB.
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very difficult to adapt the binding site of the Zm-Pdc larger ketoacid substrates. On the other hand, the substrate 
binding site in KdcA from L. lactis can accept a wide range and more voluminous molecules including branched 
chain substrates25. In particular, the residue Val461 (Fig. 4A) lies at the entrance of the substrate (S)-pocket to 
which it can control access. In addition, the active site of Ll-KdcA is lined with several other key residues pre-
viously identified to play a critical role in controlling substrate pocket size and acceptance of bulkier substrates, 
including Phe381, Gly402, Met538, and Phe54225. Replacement of valine at position 461 by a bulkier isoleucine 
residue is expected to further restrict the size of the S-pocket and to improve interactions with OHB in the main 
substrate channel (Fig. 4B). As reported in Table 2, the substitution of Val461 by isoleucine in Ll-KdcA indeed 
resulted in a 3-fold increase of Vmax on OHB and in a 2-fold reduction of the Km for this non-natural substrate.
Production of 1,3-propanediol from DHB. We next set out to test the possibility of converting DHB 
to PDO using the DHB dehydrogenase, OHB decarboxylase and PDO oxidoreductase enzymes. For this pur-
pose, we assembled an operon composed of genes coding for the DHB dehydrogenase Ec-LldD V108C vari-
ant, the endogenous aldehyde reductase YqhD and either one of the 4 different candidate OHB decarboxylases, 
namely Pdc, Pdc W382Q, KdcA, or KdcA V461I,. The operons were cloned into the medium-copy pACT3 vector 
yielding pPDO-1, pPDO-2, pPDO-3 and pPDO-4 (see Table 4). The resulting constructs were incubated on 
mineral medium that contained glucose as the carbon source and which was supplemented with 50 mM race-
mic (D/L)-DHB. PDO production and DHB consumption were estimated after 24h of cultivation. All strains, 
including the control strain, which only harbored an empty plasmid, consumed nearly identical amounts of DHB 
(Table 3). Furthermore, chromatographic separation of DHB stereoisomers revealed that mainly (L)-DHB was 
consumed by the bacterial cells. Since (L)-DHB is structurally similar to (L)-lactate, and since native Ec-LldD 
was shown to have activity on (L)-DHB we tested whether deletion of LldD in the wild-type strain could abolish 
DHB consumption. Indeed, we found that the ΔlldD mutant was unable of consuming DHB, thus, confirming 
the pivotal role of this enzyme in DHB assimilation (see Table 3).
Figure 3. Active site region in the crystal structure of Z. mobilis pyruvate decarboxylase (Zm-Pdc) wild-type 
(A) and W392Q (B). The synthetic 2-keto-4 hydroxybutyrate (OHB) substrate was manually docked into the 
X-ray structure of the enzyme with bound pyruvate (Pyr) and a TPP analogue complexed with a Mg2+ ion (PDB 
code 2wva). The individual mutation at residue 392 was introduced to Zm-Pdc manually in Pymol and resulting 
change in pocket size is shown.
Strain Genes expressed
(D/L)-DHB 
consumed 
[mM]
(L)-DHB 
consumed 
[mM]
PDO 
produced 
[mM]
PDO 
conversion 
from 
L-DHB [%]
Pen946 pACT3 9.9 (±2.8) 9.4 (±2.9) 0.0 (±0.0) 0
Pen911 pACT3-llDdV108C-kdcA-yqhD 11.9 (±1.2) 11.9 (±1.2) 2.0 (±0.4) 17
Pen913 pACT3-llDdV108C-kdcAV461I-yqhD 11.9 (±1.9) 9.9 (±1.0) 5.5 (±0.5) 55
Pen965 pACT3-llDdV108C-pdc-yqhD 11.6 (±4.2) 10.8 (±4.4) 1.1 (±0.5) 11
Pen966 pACT3-llDdV108C-pdcW392Q-yqhD 11.1 (±0.04) 6.4 (±0.7) 7.1 (±0.3) 110
Table 3. Production of PDO from (D/L)-DHB by E. coli MG1655 wild-type (wt) and derived host strains 
harboring PDO downstream pathway. Cells were cultivated in 250 mL non-baffled shake flasks on mineral 
medium containing 20 g L−1 glucose. At OD600 ~0.6, IPTG (1 mM) and a racemic mixture of (D/L)-DHB (50 
mM) were added to the medium. After 24 h of cell cultivation, PDO and (D/L)-DHB titers were measured. 
Reported data are the mean (±SD) of three independent replicates.
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While wild-type cells were able of consuming DHB, PDO production was only observed in cells that expressed 
PDO pathway enzymes indicating that the proposed reaction sequence is feasible and that at least part of the 
required enzymatic activities are not naturally present in E. coli. In particular, the conversion rate of L-DHB 
into PDO was impacted by OHB decarboxylase enzyme. Strains expressing Ll-KdcA V461I (strain Pen913) and 
Zm-Pdc W392Q (strain Pen966) variants showed the highest PDO titers (5.5 and 7.1 mM, respectively). Notably, 
strain Pen966 was capable of converting all the (L)-DHB that was consumed into PDO, indicating that the in vivo 
OHB decarboxylase activity of the Zm-Pdc W392Q variant is higher than that of Ll-KdcA V461.
The finding that only half the DHB initially present in the incubation medium was consumed even after 2 or 
3 days of incubation at 37 °C by the E. coli strains indicated that either the DHB uptake and/or DHB oxidation 
could restrict its assimilation. As a first step to evaluate this possibility, the PDO-producing strain Pen913 was 
incubated with increasing amounts of (D/L)-DHB (from 10 to 100 mM) and DHB consumed as well as PDO pro-
duced were determined after 24 h. The result of this experiment showed that the consumption actually increased 
with the increase of exogenous DHB concentration and reached a plateau at 50 mM, whereas PDO production 
steadily increased with the increase of DHB concentration (see Fig. S2 in Supplementary Information). This data 
supported the idea of a limitation by either the uptake or the oxidation of DHB. To distinguish between these 
two possibilities, we took into account the report of METEX26 which discussed the capacity of various permeases 
from E. coli and notably glycolate permease (GlcA) and α-ketoglutarate permease (KgtP) that may enhance DHB 
efflux. In line with this information, we investigated the effect of these aforementioned transporters on the DHB 
consumption in strains that expressed the DHB-PDO pathway. Interestingly, an increase of more than 2-fold in 
DHB consumption was observed only in strains that overexpressed glcA (Fig. S3 in Supplementary Information). 
In addition, under this condition, both (D)- and (L)- forms of DHB were consumed with 75% preference for 
(L)-DHB. While these results confirmed that the uptake of DHB is one of the limiting factors for its biocon-
version, they also showed that part of the DHB consumed is accumulated either as an intermediate of the PDO 
pathway or has been assimilated by the cells by another pathway.
Figure 4. Active site region in the crystal structure of L. lactis branched chain keto-acid decarboxylase (Ll-
KdcA) wild-type (A) and V461I (B). The X-ray structure bound with a TPP analogue complexed with a Mg2+ 
ion (PDB code 2vbg) was aligned with Zm-Pdc structure (PDB code 2wva) crystalized with pyruvate bound. 
Upon protein structure overlay, the Zm-Pdc structure was hidden, leaving only the pyruvate, TPP analogue 
and Mg2+ and the Ll-KdcA active site shown. The pyruvate molecule served as an indicator of the putative 
binding position and orientation of the 2-ketoacid substrates within Ll-KdcA, after which the synthetic 2-keto-4 
hydroxybutyrate (OHB) substrate was manually docked. The individual mutation at valine residue 461 was 
introduced to Ll-KdcA manually in Pymol and resulting change in pocket size is shown.
Plasmid Relevant characteristics Source
pACT3 CmR; p15A ori; promoter pTAC 42
pEXT20 AmpR; colE1 ori; promoter pTAC 42
pPDO-1 pACT3-llDV108c-kdcA-yqhD This work
pPDO-2 pACT3-llDV108c-kdcAV461I-yqhD This work
pPDO-3 pACT3-llDV108c-pdc-yqhD This work
pPDO-4 pACT3-llDV108c-pdcW392Q-yqhD This work
pPDO-5 pEXT20-llDV108c-pdcW392Q-yqhD This work
pPDO-6 PEXT20-llDV108c-kdcAV461I-yqhD This work
Table 4. Plasmids constructed in this work.
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Production of 1,3-propanediol from glucose. To demonstrate PDO production directly from glucose, 
we cloned the genes coding for the complete six-reaction steps pathway into two different plasmids. The previ-
ously constructed medium-copy pDHBop-ppc* vector provided all enzymatic activities required to transform 
malate into DHB by driving the expression of malate kinase (variant Ec-LysC V115A:E119S:E250K:E434V), 
malate semialdehyde dehydrogenase (variant Bs-Asd E218Q), and malate semialdehyde reductase (variant 
Ms-Ssr H39R:N43H) enzymes19. Overexpression of the malate-insensitive phosphoenolpyruvate carboxylase 
variant Ec-Ppc K620S from the pDHBop-ppc* plasmid was previously shown to greatly increase DHB produc-
tion19,27. The three genes responsible for the conversion of DHB to PDO were cloned into a high-copy vector 
yielding pPDO-5 or pPDO-6 (see Table 4). These constructed plasmids were transformed into E. coli MG1655 
strains yielding strain CF317 (pDHBop-ppc* and pPDO-5) and CF318 (pDHBop-ppc* and pPDO-6), which 
were cultivated for 24 h on mineral medium containing 20 g.L−1 glucose as the carbon source. Only the strains 
that expressed all pathway genes produced PDO albeit at a very low level, whereas the control strain CF316 which 
only harbored pDHBop-ppc* and the empty pEXT20 plasmid was incapable of PDO production (Fig. 5). While 
it is still unclear why DHB excretion was 5-fold higher with CF318 than with CF317, these results suggested that 
the very low PDO production from glucose could be associated to a weaker catalytic capacity of the downstream 
PDO pathway as compared to that of the DHB-yielding pathway.
Besides the fact that the pathway enzymes are yet not optimal, another reason for the very weak production 
of PDO from glucose could be due to the metabolic burden on the producing strain which has to carry out two 
plasmids (medium and high copy number)28. To evaluate this possibility, we considered following a co-cultivation 
strategy in which an E. coli strain expresses the synthetic DHB-yielding pathway while another one bears the 
PDO-producing pathway. Adopting such strategy was further supported by the previous demonstration of bacterial 
co-cultures as a mean towards increased production of small molecules, including muconic acid29, 3-amino-benzoic 
acid30 and n-butanol31. The design of our co-culture strategy is shown in Fig. 6A. The upstream DHB-yielding path-
way was expressed from the CF285 strain whilst the downstream part of the pathway that converted DHB into PDO 
was expressed in the strains Pen913 or Pen966. To evaluate the performance of the co-cultivation strategy, the DHB- 
and PDO-producing strains were cultivated for 24h in a 1:1 ratio at the inoculation stage on glucose-containing 
mineral medium. In a control experiment, strain CF285 that only expresses the DHB-yielding pathway produced 
14.7 mM DHB but no PDO, whereas the co-cultivation of this strain with Pen913 or Pen 966 resulted in a PDO pro-
duction that was 5 to 8 fold higher than with a strain expressing both pathways (compared data in Fig. 5 with those 
in Fig. 6B). In both cases, DHB accumulated in the medium, which supported the idea that the PDO-producing 
pathway module is catalytically less efficient that the DHB-producing pathway module. Since the overexpression of 
glcA was found to enhance DHB uptake (see Fig. S3 in Supplementary Information), we repeated this co-cultivation 
strategy using strain CF283 (MG1655 glcAproD bearing pPDO-2 or strain CF286 (MG1655 glcAproD with pPDO-4). 
A PDO production of up to 4 mM was obtained with CF285:CF283 strain co-cultivation, whereas co-culture of 
CF285: CF286 produced only 1.5 mM PDO, confirming our earlier results (see above) that the OHB decarboxylase 
mutant Zm-Pdc W382Q was more efficient than the Ll-KdcA V461I for in vivo production PDO from glucose. In 
an attempt to increase PDO production, we doubled the amount of CF283 versus CF285 at the inoculation stage to 
compensate for the weaker activity of this pathway module. However, this change in the cultivation protocol did not 
improve PDO titers (data not shown). Altogether, these results demonstrate that the production of PDO directly 
from glucose is feasible and that, at least ate the present stage of the development, distributing pathway modules into 
two strains that are co-cultivated increases PDO titers.
Discussion
In this work, we explored the feasibility of a synthetic pathway enabling PDO biosynthesis from glucose under 
aerobic conditions via the Krebs cycle intermediate (L)-malate, which is based on the extension of a previ-
ously published (L)-DHB metabolic pathway19. The synthetic route does not involve supplementation of the 
expensive vitamin-B12 or the use of glycerol as a precursor unlike naturally occurring PDO pathways, but it 
Figure 5. PDO production from glucose after 24 h of cultivation of an E. coli monoculture system. Cells were 
cultivated in 250 mL baffled shake flasks on mineral medium containing 20 g L−1 glucose. At OD600~0.6, IPTG 
(1 mM) was added to the medium. Reported data were the mean (±SD) of at least two replicates.
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relies on NAD(P)H co-factor and ATP to achieve relevant PDO titers. In this scope, we recently engineered E. 
coli to produce malate via Krebs cycle and glyoxylate shunt, which is expected to provide additional ATP and 
NAD(P)H cofactors which are necessary to convert malate to DHB or PDO32. The theoretical yield of this Krebs 
cycle-dependent PDO production was calculated to be 1.5 mol PDO per mol glucose. Since this value is similar 
to other PDO pathways that proceed through glycerol11,17, the synthetic pathway presented here may be an alter-
native or complement for the industrially established PDO production routes.
One of the major challenges during the construction of non-natural pathways consists in finding and engi-
neering the constituting enzymes to obtain activities that are compatible with in vivo applications. The proposed 
route uses a combination of natural and engineered enzymes acting on non-natural substrates. While the three 
first catalytic steps linking (L)-malate to DHB were constructed in a previous work19, the identification and engi-
neering of enzymes catalyzing the three remaining enzymatic activities to convert DHB into PDO was targeted in 
this work. Based on a screening of candidate enzymes performing similar reactions and acting on sterically cog-
nate substrates, enzymes with (L)-DHB dehydrogenase and OHB decarboxylase activities were identified. These 
enzymes exhibited, however, weak activities on the non-natural substrates. We therefore employed a rational 
enzyme engineering strategy which relied on the previously reported structural analysis of the 2-keto acid decar-
boxylase KdcA25,33, and the Saccharomyces cerevisiae mitochondrial lactate oxidoreductase, the homologous to 
E. coli LldD34. Although the increase of activity of these enzymes on the non-natural substrates by a rational 
engineering strategy gave some limited success, it also provided interesting insights about the impact of the OHB 
decarboxylase in the DHB to PDO conversion, since only E. coli strains expressing Zm-PdcW392Q variant together 
with LldDV108C was able to convert almost all L-DHB into PDO. In the other cases, the conversion rate was 
much lower indicating that OHB obtained from the oxidation of DHB by the LldD enzyme has been diverted 
into other pathway(s). The most likely explanation is the conversion of OHB into homoserine, by mean of a 
transaminase reaction involving glutamate as the ‘NH2’ donor. This hypothesis is supported by the finding that we 
previously reported that aspartate aminotransferase encoded by aspC can catalyze the reversible reaction homo-
serine + α-ketoglutarate <−> 4-hydroxy-2-keto butyrate + glutamate27. Importantly, the direction of this reac-
tion is depending on the glutamate/ α-ketoglutarate ratio, which is very high in E. coli35. Therefore, there seems 
to be a key competition at the level of OHB between a transaminase and a decarboxylase reaction. Generation 
and screening of larger mutant libraries appears to be required for obtaining OHB decarboxylase as well as DHB 
dehydrogenase enzymes with adequate activities to solve this issue and favor the DHB-PDO production pathway. 
In this regard, our recently developed transcription-based aldehyde sensor36, which also responded to the PDO 
pathway intermediate 3-hydroxypropanal, could be an exquisite tool for in vivo screening of more efficient OHB 
decarboxylases as well as enzyme(s) mutant libraries generated of upstream reaction steps in the pathway.
Figure 6. PDO production from glucose after 24 h with two E. coli strain co-culture systems. (A) Scheme of the 
co-culture design, in which a first cell expresses the upstream pathway enabling DHB synthesis from glucose, 
while a second cell incorporated extracellularly accumulated DHB and converts it to PDO due to expression of the 
downstream PDO producing pathway. (B) Production of PDO from glucose at inoculation ratio equal to 1:1 with 
four different PDO producing strains (Pen913, Pen966, CF283, CF286) and the DHB producing strain CF285.
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Even though the constituting enzymatic activities of the synthetic pathway were rather low, we could demon-
strate a direct production of 0.1 mM PDO from 110 mM glucose by expression the whole pathway bearing six 
enzymatic reactions in a single E. coli strain. Moreover, we could show that this weak production was in part due 
the metabolic burden on the production strain, which had to carry two plasmids since a co-cultivation strategy 
where the pathway was split into two functional modules resulted in a 10-fold increase in PDO titer. Also, another 
limitation that was in part alleviated was to engineer a better uptake of the DHB through overexpression of the 
GlcA permease, which further increase to PDO production by 4-fold. While these results are in line with previ-
ous studies, which also reported increase production rates upon co-culturing strains that express only parts of 
a long metabolic pathway30, this strategy can only be applied at very early stages of process development. For an 
industrial application of this pathway it is not a preferable solution, since production of bulk chemicals such as 
PDO requires extremely high carbon yields that cannot be achieved by co-culturing two strains. Thus, obtaining 
pathway enzymes with higher activities and which will require their moderate overexpression to provide ade-
quate in vivo activities is the key for constructing robust production strains that have industrially relevant PDO 
production rates.
Methods
Chemicals and reagents. All chemicals and solvents were purchased from Sigma-Aldrich unless oth-
erwise stated. Restriction endonucleases and DNA-modifying enzymes were from New England Biolabs and 
used according to manufacturer’s instructions. DNA plasmid isolation was performed using GeneJET Plasmid 
Miniprep Kit (Thermo Scientific). DNA extraction from agarose gel was carried out using the GeneJET Gel 
Extraction Kit (Thermo Scientific). DNA sequencing was carried out by Beckman Coulter Genomics (Takeley, 
United Kingdom) or Eurofins SAS (Ebersberg, Germany). The racemic mixture of sodium (D/L)-DHB (purity, 
70%) was chemically synthetized by Adisseo SA (France).
Protein cloning and mutagenesis. E. coli DH5α (New England Biolabs) was routinely used for construc-
tion of plasmids. Wild-type Ec-lldD and Zm-pdc genes were amplified from genomic DNA (extracted from E. coli 
MG1655 and Zymomonas mobilis ATCC® 31821, respectively) by PCR. The used primers are listed in Table S2. 
The gene Ll-kdcA from Lactococcus lactis B1157-NIZO was codon-optimized for expression in E. coli and synthe-
sized by Eurofins. The resulting DNA fragments were digested with suitable restriction enzymes (Table S2) and 
cloned into the corresponding sites of pET28a vector system (Novagen) using T4 DNA ligase (Biolabs), thereby 
adding an N-terminal hexa-His tag. Point mutations were introduced on pET28-derived plasmid by inverse PCR 
using the primers listed in Table S3. Resulting products were digested by DpnI to remove template DNA and 
transformed into competent cells. The introduction of desired mutation was verified by sequencing.
Protein expression and purification. Enzymes were expressed in E. coli BL21 (DE3) cells (New England 
Biolabs) in 200 mL Luria-Bertani (LB) medium supplemented with 50 µg/mL kanamycin (37 °C, 200 rpm). 
Expression cultures were inoculated from an overnight culture at OD600 of 0.05 and grown to OD600 of 0.6 before 
protein expression was induced by addition of 1 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) to the cul-
ture medium. Cells were harvested after 3 h of incubation by centrifugation (15 min at 4,000 rpm, 4 °C) and 
pellets stored at −20 °C until further analysis. Frozen cell pellets were resuspended in 1 mL of lysis buffer (50 
mM Hepes, 300 mM NaCl, pH 7.5) and disrupted by four successive rounds of sonication (sonication interval: 
30 s, power output: 30%, sonicator: Bioblock Scientific, VibraCell™ 72437). The resulting cell crude extract was 
directly used for measurement of FMN-dependent 2-hydroxyacid dehydrogenase activities, while 2-ketoacid 
decarboxylase enzymes were purified as described elsewhere19.
Enzymatic assays. The activity of wild-type membrane-associated (L)-lactate dehydrogenase and mutant 
variant V108C assayed in the oxidative direction by monitoring reduction of 2,6-dichloroindophenol (DCIP) at 
655 nm (ε = 5.9 mM−1 cm−1) during oxidation of 2-hydroxyacids. The assay mixture contained 60 mM Hepes 
(pH 7), 50 mM KCl, 0.06 mM DCIP and appropriate amounts of crude protein extract. Reactions were started 
by adding appropriate concentrations of (L)-lactate or a racemic mixture of (D/L)-DHB (Adisseo SAS, France). 
One unit of membrane-associated dehydrogenase activity (U) was defined as the amount of enzyme catalyzing 
the conversion of 1.0 µmole of DCIP per minute.
The activity of keto-acid decarboxylase wild-type and mutant variants was assayed by coupling the decarboxy-
lation reactions to the NAD(P)H-dependent reduction of the produced aldehydes. The decarboxylation of natural 
substrates (pyruvate, 3-methyl-2-oxobutyric acid) was coupled to the NADH-dependent reduction of acetaldehyde 
catalyzed by yeast alcohol dehydrogenase (Sigma, A7011). OHB decarboxylase activity was assayed by coupling 
decarboxylase activity to the NADPH-dependent reduction of the released 3-hydroxypropanal by purified alde-
hyde reductase Ec-YqhD. The assay mixture contained 60 mM Hepes (pH 7), 50 mM KCl, 5 mM MgCl2, 0.25 mM 
NAD(P)H, 0.5 mM thiamine pyrophosphate, 100 µg mL−1 auxiliary enzyme and appropriate amounts of purified 
enzyme. Reactions were started by adding appropriate concentrations of pyruvate, 3-methyl-2-oxobutyric acid or 
OHB. The latter was synthesized in-house as previously described27. One unit of decarboxylase activity (U) was 
defined as the amount of enzyme catalyzing the conversion of 1.0 µmole of 2-ketoacid per minute
All enzyme assays were performed in a microplate reader (Epoch 2, BioTek) at 37 °C in 96-well flat-bottomed 
microtiter plates in a final volume of 250 µL. Protein concentrations were determined prior to enzymatic assays 
by Bradford method37.
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Plasmids and strains construction. Plasmids and strains that were constructed and used in this study 
are listed in Tables 4 and 5. The gene yqhD was amplified by PCR from genomic DNA with primer pairs pen290/
pen291, whilst the remaining genes were amplified from pET28-28 derived vectors using primer pairs listed 
in Table S4. DNA fragments were purified and assembled by homologous recombination with BamHI/SalI 
digested pEXT20 or pACT3 vector using the NEBuilder® HiFi DNA Assembly kit (New England Biolabs). The 
resulting plasmids were transformed into DH5α competent E. coli cells and assembled operons verified by DNA 
sequencing.
E. coli K-12 substr. MG1655 (ATCC 47076) was used as the parental strain for all constructions in this study 
(Table 5). Expression of glcA and ktgP genes was rendered constitutive by replacing the native chromosomal 
5′-UTR of each gene by the synthetic constitutive and insulated promoter proD38. The proD sequence was 
preceded by a kan resistance cassette which was amplified by PCR adding 50 bp flanking sequences that were 
homologous to the target locus. The resulting DNA fragment was used to replace the natural gene promoter by 
homologous recombination39. Primers used are listed in Table S4. Positive clones were selected on LB agar plates 
containing kanamycin (50 µg mL−1) and verified by PCR analysis. The kan cassette was removed from the genome 
by expressing FLP recombinase from the pCP20 plasmid40 and correct excision of the cassette was verified by 
PCR using locus specific primers (Table S4). Plasmids were transformed into the target E. coli strains using stand-
ard laboratory protocols41.
Condition for PDO production from DHB or Glucose. All cell cultivation was carried out at 37 °C on 
a rotary shaker (Infors HT, France) running at 200 rpm. Pre-cultures were grown in 5 mL of LB in 50 mL falcon 
tubes. After ~10 h, 500 µL were used to inoculate a second pre-culture (10 mL of 90% v/v M9 mineral medium 
supplemented with 20 g L−1 glucose and 10% v/v LB in 50 mL falcon tubes) that was cultivated overnight. The 
biomass needed to start main cultures with a starting OD600 of 0.2 was transferred to 250 mL baffled shake flasks 
containing 25 mL of 90% v/v M9 mineral medium supplemented with 20 g L−1 glucose and 10% v/v LB, and 1 
mM IPTG and 50 mM (D/L)-DHB were added when OD600 reached ~0.6. The antibiotic chloramphenicol was 
added when required at 25 mg L−1. M9 mineral medium contained: 20 g glucose, 18 g Na2HPO4*12H2O, 3 g 
KH2PO4, 0.5 g NaCl, 2 g NH4Cl, 0.5 g MgSO4*7H2O, 0.015 CaCl2*2H2O, 1 ml of 0.06 M FeCl3 stock solution 
prepared in 100 times diluted concentrated HCl, 2 ml of 10 mM thiamine HCl stock solution, 20 g MOPS, and 
1 ml of trace element solution (containing per liter: 0.04 g Na2EDTA*2H2O, 0.18 g CoCl2*6H2O, ZnSO4*7H2O, 
0.04 g Na2MoO4*2H2O, 0.01 g H3BO3, 0.12 g MnSO4*H2O, 0.12 g CuCl2*H2O). The pH was adjusted to 7.0 and 
the medium was filter-sterilized.
Pre-culture was made in 5 mL of LB in 50 mL falcon tubes. After ~10 h, 500 µL were used to inoculate a second 
pre-culture (10 mL of M9 mineral medium supplemented with 20 g L−1 glucose in 50 mL falcon tubes) that was 
cultivated overnight. The biomass needed to start main cultures with a starting OD600 of 0.2 was transferred to 250 
mL baffled shake flasks containing 25 mL of M9 mineral medium supplemented with 20 g L−1 glucose. The anti-
biotics ampicillin, kanamycin sulphate and chloramphenicol were added when required, respectively, at 100, 50 
and 25 mg L−1. IPTG (1 mM) was added after 3 h of cell cultivation. In co-cultivation experiments, the different 
strains were inoculated at a ratio described in the text.
Analytical methods. Extracellular concentrations of metabolites were determined on a Dionex Ultimate 
3,000 HPLC system (Thermo Scientific, France) equipped with a RI detector (RID-10A, Shimadzu, Japan) and 
UV/Vis detector (SPD-20A, Shimadzu). The sample injection volume was 20 μL. Glucose and (D/L)-DHB were 
Strain Genotype Source
NEB5-α E. coli fhuA2 Δ(argF-lacZ)U169 phoA glnV44 Φ80Δ  (lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17 NEB
BL21 (DE3) E. coli fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS NEB
MG1655 E. coli F−λ− ilvG-rfb-50 rph-1 ATCC 47076
CF220 MG1655 glcAproD This work
CF221 MG1655 kgtPproD This work
Pen946 MG1655/pACT3 This work
Pen911 MG1655/pPDO-1 This work
Pen913 MG1655/pPDO-2 This work
Pen965 MG1655/pPDO-3 This work
Pen966 MG1655/pPDO-4 This work
CF285 MG1655/pDHBop (ppc*) 19
CF316 CF285/pEXT20 This work
CF317 CF285/pPD0-5 This work
CF318 CF285/pPDO-6 This work
CF283 CF220/pPDO-2 This work
CF284 CF221/pPDO-2 This work
CF286 CF220/pPDO-4 This work
Table 5. Strains used in this work.
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measured with the RI detector by using a cation-exchange column (Rezex RoA-organic acid H+ 8%) preceded 
by a SecurityGuard guard cartridge (Phenomenex, USA). The separation was performed at 80 °C with 0.5 mM 
H2SO4 at 0.5 mL min−1 as mobile phase. PDO concentrations (from RI detector) were measured using an Aminex 
HPX-87H column protected by a Micro-Guard Cation H+ pre-column (BioRad, USA). The separation was per-
formed at 35 °C with 1.25 mM H2SO4 at 0.5 mL min−1. Amounts of D-DHB were estimated on the UV detector 
(at 254 nm) by using a Chirex 3126 column (Phenomenex, USA) with an aqueous mobile phase containing 2 
mM CuSO4 and 15% methanol. Flow rate was 1 mL/min, and the column was held at 22 °C. Concentrations of 
(L)-DHB were estimated by subtracting estimated amounts of the (D)-form to total (D/L)-DHB. All samples were 
centrifuged (2 min at 13,000 rpm) and syringe-filtered (0.2 µm), and the resulting supernatant stored at −20 °C 
before analysis. A standard calibration curve was obtained by injecting standards.
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